Haplotype sharing suggests that a genomic segment containing six genes accounts for the pulmonary adenoma susceptibility 1 (Pas1) locus activity in mice

Oncogene

Volumn 23, Issue 25, 2004, Pages 4495-4504

  Manenti, Giacomo ^a   Galbiati, Federica ^a   Giannì Barrera, Roberto ^a   Pettinicchio, Angela ^a   Acevedo, Abraham ^b   Dragani, Tommaso A ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSIDAD DE LA LAGUNA   (Spain)

Author keywords

Genetic susceptibility; Inbred strains; Kras2; Lung tumors

Indexed keywords

ALLELE; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CANCER SUSCEPTIBILITY; DNA POLYMORPHISM; DOWN REGULATION; EXON; FEMALE; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCUS; GENOME; GENOTYPE; HAPLOTYPE; INTRON; LUNG ADENOMA; MALE; MARKER GENE; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; A J MOUSE; ADENOMA; AMINO ACID SUBSTITUTION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; CHROMOSOME MAP; CROSS BREEDING; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC PREDISPOSITION; GENETICS; LUNG; LUNG TUMOR; METABOLISM; MULTIFACTORIAL INHERITANCE; PHYSIOLOGY; SEQUENCE HOMOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR SUPPRESSOR GENE;

ANIMALIA;

AMINOTRANSFERASE; BCAT1 PROTEIN, MOUSE; LAS1 PROTEIN, MOUSE; LMNA RS1 PROTEIN, MOUSE; LMNA-RS1 PROTEIN, MOUSE; LRMP PROTEIN, MOUSE; MEMBRANE PROTEIN; MESSENGER RNA; RNA; TUMOR SUPPRESSOR PROTEIN; URETHAN;

ADENOMA; ALLELES; AMINO ACID SUBSTITUTION; ANIMALS; CHROMOSOME MAPPING; CROSSES, GENETIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENES, TUMOR SUPPRESSOR; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; LUNG; LUNG NEOPLASMS; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED A; MICE, INBRED C57BL; MULTIFACTORIAL INHERITANCE; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, MESSENGER; RNA, NEOPLASM; SEQUENCE HOMOLOGY, AMINO ACID; TRANSAMINASES; TUMOR SUPPRESSOR PROTEINS; URETHANE;

EID: 3042578627     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207584     Document Type: Article

References (35)

1. Akamatsu Y. (1975). J. Natl. Cancer Inst., 55, 893-897.
2. Askling J, Grunewald J, Eklund A, Hillerdal G and Ekbom A. (1999). Am. J. Respir. Crit. Care Med., 160, 1668-1672.
3. Bauer AK, Dwyer-Nield LD, Keil K, Koski K and Malkinson AM. (2001). Exp. Lung Res., 27, 197-216.
4. Behrens TW, Jagadeesh J, Scherle P, Kearns G, Yewdell J and Staudt LM. (1994). J. Immunol., 153, 682-690.
5. Brownson RC and Alavanja MC. (2000). Cancer Causes Control, 11, 853-858.
6. Burkhard P, Stetefeld J and Strelkov SV. (2001). Trends Cell Biol., 11, 82-88.
7. Cormier R, Hong K, Halberg R, Hawkins T, Richardson P, Mulherkar R, Dove W and Lander ES. (1997). Nat. Genet., 17, 88-91.
8. Cormier RT, Bilger A, Lillich AJ, Halberg RB, Hong KH, Gould KA, Borenstein N, Lander ES and Dove WF. (2000). Oncogene, 19, 3182-3192.
9. Darvasi A and Pisante-Shalom A. (2002). Trends Genet., 18, 489-191.
10. De Luca M, Roshina NV, Geiger-Thornsberry GL, Lyman RF, Pasyukova EG and Mackay TF. (2003). Nat. Genet., 34, 429-433.
11. Devereux TR, Wiseman RW, Kaplan N, Garren S, Foley JF, White CM, Anna C, Watson MA, Patel A, Jarchow S, Maronpot RR and Anderson MW. (1994). Mamm. Genome, 5, 749-755.
12. Dragani TA. (2003). Cancer Res., 63, 3011-3018.
13. Eden A and Benvenisty N. (1999). FEBS Lett., 457, 255-261.
14. Festing MFW, Yang A and Malkinson AM. (1994). Genet. Res., 64, 99-106.
15. Gariboldi M, Manenti G, Canzian F, Falvella FS, Radice MT, Pierotti MA, Della Porta G, Binelli G and Dragani TA. (1993). Nat. Genet., 3, 132-136.
16. Hanahan D and Weinberg RA. (2000). Cell, 100, 57-70.
17. Johnson L, Mercer K, Greenbaum D, Bronson RT, Crowley D, Tuveson DA and Jacks T. (2001). Nature, 410, 1111-1116.
18. Kawakami K, Salonga D, Park JM, Danenberg KD, Uetake H, Brabender J, Omura K, Watanabe G and Danenberg PV. (2001). Clin. Cancer Res., 7, 4096-4101.
19. Liang T, Spence J, Liu L, Strother WN, Chang HW, Ellison JA, Lumeng L, Li TK, Foroud T and Carr LG. (2003). Proc. Natl. Acad. Sci. USA, 100, 4690-4695.
20. Malkinson AM. (1989). Toxicology, 54, 241-271.
21. Malkinson AM and Beer DS. (1984). J. Natl. Cancer Inst., 73, 925-933.
22. Manenti G, Acevedo A, Galbiati F, Giannì Barrera R, Noci S and Dragani TA. (2002). Int. J. Cancer, 99, 555-559.
23. Manenti G, Stafford A, De Gregorio L, Gariboldi M, Falvella FS, Avner P and Dragani TA. (1999). Genome Res., 9, 639-646.
24. Maria DA, Manenti G, Galbiati F, Ribeiro OG, Cabrera WK, Giannì Barrera R, Pettinicchio A, De Franco M, Starobinas N, Siqueira M, Dragani TA and Ibanez OM. (2003). Oncogene, 22, 426-432.
25. Mayne ST, Buenconsejo J and Janerich DT. (1999). Am. J. Epidemiol., 149, 13-20.
26. Re FC, Manenti G, Borrello MG, Colombo MP, Fisher JH, Pierotti MA, Della Porta G and Dragani TA. (1992). Mol. Carcinogen., 5, 155-160.
27. Shaughnessy Jr JD, Largaespada DA, Tian E, Fletcher CF, Cho BC, Vyas P, Jenkins NA and Copeland NG. (1999). Oncogene, 18, 2069-2084.
28. Steinmetz LM, Sinha H, Richards DR, Spiegelman JI, Oefner PJ, McCusker JH and Davis RW. (2002). Nature, 416, 326-330.
29. Trainin N, Linker-Israeli M, Small M and Boiato-Chen L. (1967). Int. J. Cancer, 2, 326-336.
30. Wade CM, Kulbokas III EJ, Kirby AW, Zody MC, Mullikin JC, Lander ES, Lindblad-Toh K and Daly MJ. (2002). Nature, 420, 574-578.
31. Wang M, Lemon WJ, Liu G, Wang Y, Iraqi FA, Malkinson AM and You M. (2003). Cancer Res., 63, 3317-3324.
32. Webb KE, Martin JF, Cotton J, Erusalimsky JD and Humphries SE. (2003). Exp. Hematol., 31, 488-494.
33. Wiltshire T, Pletcher MT, Batalov S, Barnes SW, Tarantino LM, Cooke MP, Wu H, Smylie K, Santrosyan A, Copeland NG, Jenkins NA, Kalush F, Mural RJ, Glynne RJ, Kay SA, Adams MD and Fletcher CF. (2003). Proc. Natl. Acad. Sci. USA, 100, 3380-3385.
34. Zhang Z, Futamura M, Vikis HG, Wang M, Li J, Wang Y, Guan KL and You M. (2003). Proc. Natl. Acad. Sci. USA, 100, 12642-12647.
35. Zhang Z, Wang Y, Vikis HG, Johnson L, Liu G, Li J, Anderson MW, Sills RC, Hong HL, Devereux TR, Jacks T, Guan KL and You M. (2001). Nat. Genet., 29, 25-33.